However, advances in treatment have made it possible for more and more patients to be accurately diagnosed, seek the most appropriate treatment, and live with the disease. Dotatate gallium (Ga-68) (Ga-DOTATATE ) under the brand name NETSPOT is indicated for use with positron emission tomography (PET) for localization of somatostatin receptor positive neuroendocrine tumors (NETs) in adult and pediatric patients. NETSPOT is supplied as a single-dose kit (NDC 69488-001-40) for preparing a single dose of gallium 68 (Ga 68) radiolabeled dotatate injection. Clinical Policy Title: Gallium Ga68 dotatate. This can lead to delays in diagnosis or even misdiagnosis and inappropriate treatment. Gallium ga-68, dotatate, diagnostic, 0. Symptoms often resemble those of other diseases, like sweating, diarrhea, abdominal pain, and GI bleeding. A gallium scan is a type of nuclear medicine test that uses either a gallium-67 (67Ga) or gallium-68 (68Ga) radiopharmaceutical to obtain images of a. They have become the second most common cancer of the gastrointestinal tract. AmeriHealth Caritas considers the use of gallium Ga68 dotatate (Netspot) scans to be clinically proven and, therefore, medically necessary when the.
There are several types of NETs, but most occur throughout the gastrointestinal tract and lungs. What are Neuroendocrine Tumors? Neuroendocrine Tumors (NETs) are a group of uncommon tumors. Gallium-68 dotatate (NETSPOT) is a new FDA-approved radiopharmaceutical test that makes Neuroendocrine Tumors visible on medical images for the purpose of accurate diagnosis and tracking. This scan helps accurately locate and characterize tumors in adult patients with somatostatin-receptor positive Neuroendocrine Tumors (NETs). NETSPOT is administered with a recommended dose of 2MBq/kg of body weight (0.054 mCi/kg) up to 200 MBq (5.4 mCi) administered as an intravenous bolus injection. Home HCPCS Codes Code Section HCPCS Index Type of Service. What is NETSPOT (Gallium-68)? NETSPOT is the first Gallium-68 injection, a radioactive diagnostic agent for PET/CT imaging. Toggle navigation 2022 HCPCS Codes Level II.
0 kommentar(er)
